T Kerola, T Nieminen, S Hartikainen, R Sulkava, O Vuolteenaho & R Kettunen Scand J Clin Lab Invest. 2009; 69:865–872. DOI: 10.3109/00365510903359237
On page 865 the sentence:
When tested as a dichotomous variable (EF > or ≤45%), the only variables to show significant association with ejection fraction were age (odds ratio [OR] = 0.65 for a change of one standard deviation in age; p = 0.002), total cholesterol (OR = 1.43; p = 0.025), HDL (OR = 1.51; p = 0.013) and use of Angiotensin converting enzyme-inhibitor or Angiotensinogen receptor II-blocker (OR = 0.23; p = 0.046).
should have read:
When tested as a dichotomous variable (EF > or ≤45%), the only variables to show significant association with ejection fraction were age (odds ratio [OR] = 0.65 for a change of one standard deviation in age; p = 0.002), total cholesterol (OR = 1.43; p = 0.025), HDL (OR = 1.51; p = 0.013) and use of angiotensin converting enzyme-inhibitor or angiotensin II receptor blocker (OR = 0.23; p = 0.046).
On page 866 the sentence:
Left ventricular mass was calculated (LV mass = 0.8 × 1.04[(LVIDd + PWTd + SWTd)3’’’ (LVIDd)3] + 0.6) and indexed to the body surface area.
should have read:
Left ventricular mass was calculated (LV mass = 0.8 × 1.04[(LVIDd + PWTd + SWTd)3+(LVIDd)3] + 0.6) and indexed to the body surface area.
On page 869, the title to Table II:
Logistic regression analysis presenting Odds ratios and their significance of clinical variables for their association with the ejection fraction as a dichotomous (# or . 0.45) variable and, similarly, linear analysis, standardized regression coefficient (beta) and their significance, with the ejection fraction as a continuous variable.
should have read:
Logistic regression analysis presenting Odds ratios and their significance of clinical variables for their association with the ejection fraction as a dichotomous (≤ or > 0.45) variable and, similarly, linear analysis, standardized regression coefficient (beta) and their significance, with the ejection fraction as a continuous variable.
On page 869, the legend to Table II:
Smoking was changed as a dichotomous variable, non-smoker vs. ex-smokers and smokers. NYHA, New York Heart Association class was reclassified, class I and II vs. III and IV. ASO, arteriosclerosis obliterans; LDL, low-density lipoprotein; HDL, high-density lipoprotein; ACE-i, Angiotensin converting enzyme inhibitor; ARB, Angiotensin receptor II-blocker; Other cardiovascular drugs, beta-blockers, calcium-channel antagonists and diuretics analysed separately.
should have read:
Smoking was changed as a dichotomous variable, non-smoker vs. ex-smokers and smokers. NYHA, New York Heart Association class was reclassified, class I and II vs. III and IV. ASO, arteriosclerosis obliterans; LDL, low-density lipoprotein; HDL, high-density lipoprotein; ACE-i, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker; other cardiovascular drugs, beta-blockers, calcium-channel antagonists and diuretics analysed separately.
On page 869, the legend to Table III:
HDL, high-density lipoprotein; ACE-I, Angiotensin converting enzyme inhibitor; ARB, Angiotensinogen receptor II-blocker.
should have read:
HDL, high-density lipoprotein; ACE-I, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker.
On page 870 the x-axis to Figure 1B:
HDL < 1mmol/l HDL > = Lmmol/l
should have read:
HDL < 1mmol/l HDL ≥ 1mmol/l
The publisher apologizes to the authors of the article and our readers for these composition errors.